Design, Synthesis and Evaluation of Potential Inhibitors for Poly(ADP-Ribose) Polymerase Members 1 and 14

References

• Khodyreva SN , PrasadR , IlinaESet al. Apurinic/apyrimidinic (AP) site recognition by the 5′-dRP/AP lyase in poly(ADP-ribose) polymerase-1 (PARP-1). Proc. Natl Acad. Sci. U. S. A.107(51), 22090–22095 (2010).
   PubMed Web of Science ®Google Scholar
• Hegde ML , HazraTK , MitraS. Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells. Cell. Res.18(1), 27–47 (2008).
   PubMed Web of Science ®Google Scholar
• Haince JF , KozlovS , DawsonVLet al. Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents. J. Biol. Chem.282(22), 16441 (2007).
   PubMed Web of Science ®Google Scholar
• Gagné JP , IsabelleM , LoKSet al. Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res.36(22), 6959–6976 (2008).
   PubMed Web of Science ®Google Scholar
• Pleschke JM , KleczkowskaHE , StrohmM , AlthausFR. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J. Biol. Chem.275(52), 40974 (2000).
   PubMed Web of Science ®Google Scholar
• Fu D , CalvoJA , SamsonLD. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat. Rev. Cancer.12(2), 104–120 (2012).
   PubMed Web of Science ®Google Scholar
• Dantzer F , DeLa Rubia G , Ménissier-DeMurcia J , HostomskyZ , DeMurcia G , SchreiberV. Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1. Biochemistry39(25), 7559–7569 (2000).
   PubMed Web of Science ®Google Scholar
• Bryant HE , PetermannE , SchultzNet al. PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination. EMBO J.28(17), 2601–2615 (2009).
   PubMed Web of Science ®Google Scholar
• Amé JC , SpenlehauerC , DeMurcia G. The PARP superfamily. BioEssays26(8), 882–893 (2004).
   PubMed Web of Science ®Google Scholar
• Kim MY , ZhangT , KrausWL. Poly(ADP-ribosyl)ation by PARP-1: ‘PAR-laying’ NAD+ into a nuclear signal. Genes Dev.19(17), 1951–1967 (2005).
   PubMed Web of Science ®Google Scholar
• Xu R , ZhangC , ShinDYet al. C-Jun N-terminal kinases (JNKs) are critical mediators of osteoblast activity in vivo. J. Bone Miner. Res.32(9), 1811–1815 (2017).
   PubMed Web of Science ®Google Scholar
• Iansante V , ChoyPM , FungSWet al. PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation. Nat. Commun.6, 7882 (2015).
   PubMed Web of Science ®Google Scholar
• Alvarez-Gonzalez R , JacobsonMK. Characterization of polymers of adenosine diphosphate ribose generated in vitro and in vivo. Biochemistry26(11), 3218–3224 (1987).
   PubMed Web of Science ®Google Scholar
• Vyas S , ChangP. New PARP targets for cancer therapy. Nat. Rev. Cancer14(7), 502–509 (2014).
   PubMed Web of Science ®Google Scholar
• Kleine H , PorebaE , LesniewiczKet al. Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol. Cell32(1), 57–69 (2008).
   PubMed Web of Science ®Google Scholar
• Walford HH , DohertyTA. STAT6 and lung inflammation. JAKSTAT2(4), e25301 (2013).
   PubMedGoogle Scholar
• Tang SX , YuBH , XuXLet al. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes. J. Clin. Pathol.70(11), 926–934 (2017).
   PubMed Web of Science ®Google Scholar
• Schweiker SS , TauberAL , SherryME , LevonisSM. Structure, function and inhibition of poly(ADP-ribose)polymerase, member 14 (PARP14). Mini. Rev. Med. Chem.18(19), 1659–1669 (2018).
   PubMed Web of Science ®Google Scholar
• Butepage M , EckeiL , VerheugdP , LuscherB. Intracellular mono-ADP-ribosylation in signaling and disease. Cells4(4), 569–595 (2015).
   PubMed Web of Science ®Google Scholar
• Tauber AL , SchweikerSS , LevonisSM. Recent developments in PARP14 research. Future Med. Chem.12(18), 1657–1667 (2020).
   PubMed Web of Science ®Google Scholar
• Lin KY , KrausWL. PARP inhibitors for cancer therapy. Cell169(2), 183 (2017).
   PubMed Web of Science ®Google Scholar
• Garcia-Parra J , DalmasesA , MoranchoBet al. Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer. Eur. J. Cancer50(15), 2725–2734 (2014).
   PubMed Web of Science ®Google Scholar
• Litton JK , RugoHS , EttlJet al. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. N. Engl J. Med.379(8), 753–763 (2018).
   PubMed Web of Science ®Google Scholar
• Jiang X , LiW , LiX , BaiH , ZhangZ. Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer. Cancer Manag. Res.11, 4371–4390 (2019).
   PubMed Web of Science ®Google Scholar
• Dobzhansky T . Genetics of natural populations; recombination and variability in populations of Drosophila pseudoobscura. Genetics31(3), 269–290 (1946).
   PubMed Web of Science ®Google Scholar
• Riley JP , KulkarniA , MehrotraPet al. PARP-14 binds specific DNA sequences to promote Th2 cell gene expression. PLoS One8(12), e83127 (2013).
   PubMed Web of Science ®Google Scholar
• Yelamos J , FarresJ , LlacunaL , AmpurdanesC , Martin-CaballeroJ. PARP-1 and PARP-2: new players in tumour development. Am. J. Cancer Res.1(3), 328–346 (2011).
   PubMed Web of Science ®Google Scholar
• Manikanta Swamy M , MayurCY. Current overview on the usage of poly(ADP-ribose)polymerase (PARP) inhibitors in treating cancer. Clin. Cancer Drugs1(2), 127–148 (2014).
   Google Scholar
• Bai P , CantóC. The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab.16(3), 290–295 (2012).
   PubMed Web of Science ®Google Scholar
• Bryant HE , SchultzN , ThomasHDet al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature434(7035), 913–917 (2005).
   PubMed Web of Science ®Google Scholar
• Underhill C , ToulmondeM , BonnefoiH. A review of PARP inhibitors: from bench to bedside. Ann. Oncol.22(2), 268–279 (2011).
   PubMed Web of Science ®Google Scholar
• Makogon N , VoznesenskayaT , BryzginaT , SukhinaV , GrushkaN , AlexeyevaI. Poly(ADP-ribose) polymerase inhibitor, 3-aminobenzamide, protects against experimental immune ovarian failure in mice. Reprod. Biol.10(3), 215–226 (2010).
   PubMed Web of Science ®Google Scholar
• Lipinski CA , LombardoF , DominyBW , FeeneyPJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev.46(1), 3–26 (2001).
   PubMed Web of Science ®Google Scholar
• Loughlin WA , JenkinsID , KarisND , SchweikerSS , HealyPC. 2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: design, synthesis and structure-activity relationship study. Eur. J. Med. Chem.111, 1–14 (2016).
   PubMed Web of Science ®Google Scholar
• Daina A , ZoeteV. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. Chem. Med. Chem.11(11), 1117–1121 (2016).
   Google Scholar
• Daina A , MichielinO , ZoeteV. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep.7(1), 42717 (2017).
   PubMed Web of Science ®Google Scholar
• Schweiker SS , LevonisSM. Navigating the intricacies of molecular docking. Future Med. Chem.12(6), 469–471 (2020).
   PubMed Web of Science ®Google Scholar
• Lohning AE , LevonisSM , Williams-NoonanB , SchweikerSS. A practical guide to molecular docking and homology modelling for medicinal chemists. Curr. Top. Med. Chem.17(18), 2023–2040 (2017).
   PubMed Web of Science ®Google Scholar
• Janiak C . A critical account on π–π stacking in metal complexes with aromatic nitrogen-containing ligands. J. Chem. Soc. Dalton Transactions2000(21), 3885–3896 (2000).
   Google Scholar
• Brown JA , MaralaRB. Development of a high-throughput screening-amenable assay for human poly(ADP-ribose) polymerase inhibitors. J. Pharmacol. Toxicol. Methods47(3), 137–141 (2002).
   PubMed Web of Science ®Google Scholar
• Hopkins TA , AinsworthWB , EllisPAet al. PARP1 trapping by PARP inhibitors drives cytotoxicity in both cancer cells and healthy bone marrow. Mol. Cancer Res.17(2), 409 (2019).
   PubMed Web of Science ®Google Scholar
• Pettersen EF , GoddardTD , HuangCCet al. UCSF chimera – a visualization system for exploratory research and analysis. J. Comput. Chem.25(13), 1605–1612 (2004).
   PubMed Web of Science ®Google Scholar
• Dallakyan S , OlsonAJ. Small-molecule library screening by docking with PyRx. Methods Mol. Biol.1263, 243–250 (2015).
   PubMedGoogle Scholar
• Schweiker SS , TauberAL , KamCM , EyckensDJ , HendersonLC , LevonisSM. α-aminophosphonates as potential PARP1 inhibitors. ChemistrySelect5(14), 4205–4209 (2020).
   Web of Science ®Google Scholar
• Brown JA , MaralaRB. Development of a high-throughput screening-amenable assay for human poly(ADP-ribose) polymerase inhibitors. J. Pharmacol. Toxicol. Methods47(3), 137–141 (2002).
   PubMed Web of Science ®Google Scholar